(GILD) Top Franklin Templeton Funds – Mutual Fund Education

November 11th, 2009

Franklin Biotechnology Discovery A (MAPTX) seeks capital appreciation by primarily investing in securities of biotechnology companies and discovery research firms.

This non-diversified fund may invest a substantial portion of assets in equity securities of smaller capitalization companies with a market capitalization of less than $1.5 billion.

Gilead Sciences Inc. (GILD), Celgene Corp. (CELG) and Genzyme Corp. (GENZ) are among the fund’s key holdings.

Templeton Developing Markets A (TEDMX) seeks long-term capital appreciation through investment in securities of emerging economies.

The fund may invest up to 20% of net assets in the securities of issuers in developed market countries. It may also invest in exchange-traded funds to gain exposure to certain segments of the equity markets while maintaining liquidity.

J. Mark Mobius has been lead manager at the fund since October 1991. The fund distributes dividends and capital gains, if any, annually.

Click here to see all the mutual funds offered by Matthews International.

Zacks Investment Research

More on this topic (What's this?)
Top 10 reasons ETF’s are superior to Mutual Funds (Intelligent Speculator, 10/12/09)
Mutual funds to become extinct?? (Intelligent Speculator, 1/22/10)
RE: Care to give me a hand? (Real Wealth - Global Wealth Report, 1/22/10)
Your Mutual Fund May Be Ripping You Off (The DIV-Net, 12/22/09)
Read more on Gilead Sciences, Mutual Funds at Wikinvest


Similar Posts: | | | | | | Biotechnology | Healthcare

RSS feeds: CELG | Celgene Corporation | GENZ | Genzyme Corporation | GILD | Gilead Sciences Inc | Biotechnology | Healthcare |

Other Posts by vitalstocks | RSS Feed for this author

Post a Response

You must be logged in to post a comment.